|
Market Closed -
Nasdaq
01:30:00 20/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 7.050 USD | +4.75% |
|
-2.22% | -32.86% |
| 14/10 | Stifel Initiates Immatics at Buy With $15 Price Target | MT |
| 02/10 | Nanobiotix Names New Finance Chief | MT |
Company Valuation: Immatics N.V.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 845.5 | 663.9 | 891.4 | 848.6 | 1,408 | 919.9 | - | - |
| Change | - | -21.47% | 34.26% | -4.8% | 65.88% | -34.65% | - | - |
| Enterprise Value (EV) 1 | 710 | 289.7 | 445.7 | 610.6 | 1,026 | 633.7 | 581.2 | 650.2 |
| Change | - | -59.19% | 53.83% | 36.99% | 68% | -38.22% | -8.29% | 11.88% |
| P/E | -8.25x | 14.7x | -8.08x | 47.1x | -5.61x | -3.22x | -3.28x | -3.74x |
| PBR | - | - | - | - | 2.51x | - | - | - |
| PEG | - | -0x | 0x | -0x | 0x | -0.3x | 1.65x | 0.3x |
| Capitalization / Revenue | 22.1x | 3.57x | 15.2x | 5.05x | 25.1x | 20.1x | 23.2x | 7.79x |
| EV / Revenue | 18.5x | 1.56x | 7.6x | 3.63x | 18.3x | 13.9x | 14.6x | 5.51x |
| EV / EBITDA | -7.96x | 7.29x | -4.34x | -21.5x | -5.2x | -2.16x | -1.76x | -1.75x |
| EV / EBIT | -7.47x | 8.99x | -4.04x | -14.7x | -4.85x | -2.04x | -1.69x | -1.97x |
| EV / FCF | -7.43x | - | -32.6x | -3.25x | -4.84x | -3.2x | -1.88x | -2.11x |
| FCF Yield | -13.5% | - | -3.06% | -30.8% | -20.7% | -31.3% | -53.3% | -47.4% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.63 | 0.592 | -1.303 | 0.151 | -1.872 | -2.093 | -2.052 | -1.798 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 38.29 | 186 | 58.62 | 168.1 | 56.13 | 45.73 | 39.73 | 118.1 |
| EBITDA 1 | -89.24 | 39.74 | -102.6 | -28.46 | -197.3 | -293.4 | -329.3 | -370.9 |
| EBIT 1 | -95.04 | 32.24 | -110.4 | -41.65 | -211.7 | -311.1 | -343.1 | -329.9 |
| Net income 1 | -102.8 | 40.38 | -105.3 | 16.41 | -228.5 | -287.1 | -313.5 | -292.1 |
| Net Debt 1 | -135.5 | -374.2 | -445.8 | -238.1 | -381.9 | -286.2 | -338.7 | -269.7 |
| Reference price 2 | 13.440 | 8.710 | 10.530 | 7.110 | 10.500 | 6.730 | 6.730 | 6.730 |
| Nbr of stocks (in thousands) | 62,909 | 76,227 | 84,656 | 1,19,356 | 1,34,064 | 1,36,690 | - | - |
| Announcement Date | 23/03/22 | 21/03/23 | 21/03/24 | 27/03/25 | 05/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.22x | 13.86x | -2.16x | -.--% | 92Cr | ||
| 18.77x | 6.69x | 13.41x | 1.58% | 6.5TCr | ||
| 35.3x | 6.27x | 18.74x | 0.92% | 5.12TCr | ||
| 27.56x | 7.53x | 23.83x | 0.05% | 5.12TCr | ||
| 34.01x | 3.32x | 14.33x | -.--% | 4.39TCr | ||
| 48.9x | 5.59x | 30.73x | -.--% | 4.2TCr | ||
| -18.47x | 189.62x | -19.51x | -.--% | 3.81TCr | ||
| 28.97x | 8.21x | 21.25x | 0.37% | 3.32TCr | ||
| 29.19x | 6.17x | 16.01x | -.--% | 2.52TCr | ||
| 30.74x | 5.69x | 19.09x | -.--% | 2.25TCr | ||
| Average | 23.17x | 25.30x | 13.57x | 0.29% | 3.73TCr | |
| Weighted average by Cap. | 25.90x | 24.98x | 15.44x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IMTX Stock
- Valuation Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
















